HAE's Plasma franchise and NexSys PCS momentum may support growth, but heavy debt and competitive pressure remain key ...
Haemonetics (HAE) has redrawn its business map by merging its Plasma and Blood Center units into a single Apheresis segment and renaming its Hospital segment as MedSurg, aligning reporting with how ...
View Haemonetics Corporation HAE stock quote prices, financial information, real-time forecasts, and company news from CNN.
StockStory.org on MSN
3 reasons HAE is risky and 1 stock to buy instead
Over the last six months, Haemonetics’s shares have sunk to $75.12, producing a disappointing 7.2% loss - a stark contrast to ...
BOSTON, Jan. 14, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, ...
Learn more about whether Butterfly Network, Inc. or Haemonetics Corporation is a better investment based on AAII's A+ ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Haemonetics Corporation HAE is progressing well with its growth strategies like the expansion of the product portfolio within its plasma and Hemostasis Management franchise. However, economic ...
We believe that the stock price of Haemonetics (NYSE: HAE), best known for its blood and plasma supplies and services, is undervalued at current levels of $63. HAE stock is down 27% from the levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results